Abstract
Background: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. Methods: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested meta-regression models for severity-specific prevalence, accounting for hearing aid coverage, cause, and the presence of tinnitus. We also forecasted the prevalence of hearing loss until 2050. Findings: An estimated 1·57 billion (95% uncertainty interval 1·51–1·64) people globally had hearing loss in 2019, accounting for one in five people (20·3% [19·5–21·1]). Of these, 403·3 million (357·3–449·5) people had hearing loss that was moderate or higher in severity after adjusting for hearing aid use, and 430·4 million (381·7–479·6) without adjustment. The largest number of people with moderate-to-complete hearing loss resided in the Western Pacific region (127·1 million people [112·3–142·6]). Of all people with a hearing impairment, 62·1% (60·2–63·9) were older than 50 years. The Healthcare Access and Quality (HAQ) Index explained 65·8% of the variation in national age-standardised rates of years lived with disability, because countries with a low HAQ Index had higher rates of years lived with disability. By 2050, a projected 2·45 billion (2·35–2·56) people will have hearing loss, a 56·1% (47·3–65·2) increase from 2019, despite stable age-standardised prevalence. Interpretation: As populations age, the number of people with hearing loss will increase. Interventions such as childhood screening, hearing aids, effective management of otitis media and meningitis, and cochlear implants have the potential to ameliorate this burden. Because the burden of moderate-to-complete hearing loss is concentrated in countries with low health-care quality and access, stronger health-care provision mechanisms are needed to reduce the burden of unaddressed hearing loss in these settings. Funding: Bill & Melinda Gates Foundation and WHO.
Original language | English |
---|---|
Pages (from-to) | 996-1009 |
Number of pages | 14 |
Journal | The Lancet |
Volume | 397 |
Issue number | 10278 |
DOIs | |
Publication status | Published - 13 Mar 2021 |
Fingerprint
Dive into the research topics of 'Hearing loss prevalence and years lived with disability, 1990-2019: Findings from the Global Burden of Disease Study 2019'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet, Vol. 397, No. 10278, 13.03.2021, p. 996-1009.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Hearing loss prevalence and years lived with disability, 1990-2019
T2 - Findings from the Global Burden of Disease Study 2019
AU - GBD 2019 Hearing Loss Collaborators
AU - Haile, Lydia M.
AU - Kamenov, Kaloyan
AU - Briant, Paul Svitil
AU - Orji, Aislyn U.
AU - Steinmetz, Jaimie D.
AU - Abdoli, Amir
AU - Abdollahi, Mohammad
AU - Abu-Gharbieh, Eman
AU - Afshin, Ashkan
AU - Ahmed, Haroon
AU - Rashid, Tarik Ahmed
AU - Akalu, Yonas
AU - Alahdab, Fares
AU - Alanezi, Fahad Mashhour
AU - Alanzi, Turki M.
AU - Al Hamad, Hanadi
AU - Ali, Liaqat
AU - Alipour, Vahid
AU - Al-Raddadi, Rajaa M.
AU - Amu, Hubert
AU - Arabloo, Jalal
AU - Arab-Zozani, Morteza
AU - Arulappan, Judie
AU - Ashbaugh, Charlie
AU - Atnafu, Desta Debalkie
AU - Babar, Zaheer Ud Din
AU - Baig, Atif Amin
AU - Banik, Palash Chandra
AU - Bärnighausen, Till Winfried
AU - Barrow, Amadou
AU - Bender, Rose G.
AU - Bhagavathula, Akshaya Srikanth
AU - Bhardwaj, Nikha
AU - Bhardwaj, Pankaj
AU - Bibi, Sadia
AU - Bijani, Ali
AU - Burkart, Katrin
AU - Cederroth, Christopher R.
AU - Charan, Jaykaran
AU - Choudhari, Sonali Gajanan
AU - Chu, Dinh Toi
AU - Couto, Rosa A.S.
AU - Dagnew, Amare Belachew
AU - Dagnew, Baye
AU - Dahlawi, Saad M.A.
AU - Dai, Xiaochen
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Desalew, Assefa
AU - Dhamnetiya, Deepak
AU - Dhimal, Mandira Lamichhane
AU - Dhimal, Meghnath
AU - Doyle, Kerrie E.
AU - Duncan, Bruce B.
AU - Ekholuenetale, Michael
AU - Filip, Irina
AU - Fischer, Florian
AU - Franklin, Richard Charles
AU - Gaidhane, Abhay Motiramji
AU - Gaidhane, Shilpa
AU - Gallus, Silvano
AU - Ghamari, Farhad
AU - Ghashghaee, Ahmad
AU - Ghozali, Ghozali
AU - Gilani, Syed Amir
AU - Glǎvan, Ionela Roxana
AU - Golechha, Mahaveer
AU - Goulart, Barbara Niegia Garcia
AU - Gupta, Veer Bala
AU - Gupta, Vivek Kumar
AU - Hamidi, Samer
AU - Hammond, Billy Randall
AU - Hay, Simon I.
AU - Hayat, Khezar
AU - Heidari, Golnaz
AU - Hoffman, Howard J.
AU - Hopf, Kathleen Pillsbury
AU - Hosseinzadeh, Mehdi
AU - Househ, Mowafa
AU - Hussain, Rabia
AU - Hwang, Bing Fang
AU - Iavicoli, Ivo
AU - Ibitoye, Segun Emmanuel
AU - Ilesanmi, Olayinka Stephen
AU - Irvani, Seyed Sina Naghibi
AU - Islam, Sheikh Mohammed Shariful
AU - Iwagami, Masao
AU - Jacob, Louis
AU - Jayapal, Sathish Kumar
AU - Jha, Ravi Prakash
AU - Jonas, Jost B.
AU - Kalhor, Rohollah
AU - Al-Salihi, Nawzad Kameran
AU - Kandel, Himal
AU - Kasa, Ayele Semachew
AU - Kayode, Gbenga A.
AU - Khalilov, Rovshan
AU - Khan, Ejaz Ahmad
AU - Khatib, Mahalaqua Nazli
AU - Kosen, Soewarta
AU - Koyanagi, Ai
AU - Kumar, G. Anil
AU - Landires, Ivan
AU - Lasrado, Savita
AU - Lim, Stephen S.
AU - Liu, Xuefeng
AU - Lobo, Stany W.
AU - Lugo, Alessandra
AU - Makki, Alaa
AU - Mendoza, Walter
AU - Mersha, Amanual Getnet
AU - Mihretie, Kebadnew Mulatu
AU - Miller, Ted R.
AU - Misra, Sanjeev
AU - Mohamed, Teroj Abdulrahman
AU - Mohammadi, Mokhtar
AU - Mohammadian-Hafshejani, Abdollah
AU - Mohammed, Arif
AU - Mokdad, Ali H.
AU - Moni, Mohammad Ali
AU - Kandel, Sandhya Neupane
AU - Nguyen, Huong Lan Thi
AU - Nixon, Molly R.
AU - Noubiap, Jean Jacques
AU - Nuñez-Samudio, Virginia
AU - Oancea, Bogdan
AU - Oguoma, Victor Maduabuchi
AU - Olagunju, Andrew T.
AU - Olusanya, Bolajoko Olubukunola
AU - Olusanya, Jacob Olusegun
AU - Orru, Hans
AU - Owolabi, Mayowa O.
AU - Padubidri, Jagadish Rao
AU - Pakshir, Keyvan
AU - Pardhan, Shahina
AU - Kan, Fatemeh Pashazadeh
AU - Pasovic, Maja
AU - Pawar, Shrikant
AU - Pham, Hai Quang
AU - Pinheiro, Marina
AU - Pourshams, Akram
AU - Rabiee, Navid
AU - Rabiee, Mohammad
AU - Radfar, Amir
AU - Rahim, Fakher
AU - Rahimi-Movaghar, Vafa
AU - Ur Rahman, Mohammad Hifz
AU - Rahman, Mosiur
AU - Rahmani, Amir Masoud
AU - Rana, Juwel
AU - Rao, Chythra R.
AU - Rao, Sowmya J.
AU - Rashedi, Vahid
AU - Rawaf, David Laith
AU - Rawaf, Salman
AU - Renzaho, Andre M.N.
AU - Rezapour, Aziz
AU - Ripon, Rezaul Karim
AU - Rodrigues, Voilet
AU - Rustagi, Neeti
AU - Saeed, Umar
AU - Sahebkar, Amirhossein
AU - Samy, Abdallah M.
AU - Santric-Milicevic, Milena M.
AU - Sathian, Brijesh
AU - Satpathy, Maheswar
AU - Sawhney, Monika
AU - Schlee, Winfried
AU - Schmidt, Maria Ines
AU - Seylani, Allen
AU - Shaikh, Masood Ali
AU - Shannawaz, Mohammed
AU - Shiferaw, Wondimeneh Shibabaw
AU - Siabani, Soraya
AU - Singal, Anjali
AU - Singh, Jasvinder A.
AU - Singh, Jitendra Kumar
AU - Singhal, Deepika
AU - Skryabin, Valentin Yurievich
AU - Skryabina, Anna Aleksandrovna
AU - Sotoudeh, Houman
AU - Spurlock, Emma Elizabeth
AU - Taddele, Biruk Wogayehu
AU - Tamiru, Animut Tagele
AU - Tareque, Md Ismail
AU - Thapar, Rekha
AU - Tovani-Palone, Marcos Roberto
AU - Tran, Bach Xuan
AU - Ullah, Saif
AU - Tahbaz, Sahel Valadan
AU - Violante, Francesco S.
AU - Vlassov, Vasily
AU - Vo, Bay
AU - Vongpradith, Avina
AU - Vu, Giang Thu
AU - Wei, Jingkai
AU - Yadollahpour, Ali
AU - Jabbari, Seyed Hossein Yahyazadeh
AU - Yeshaw, Yigizie
AU - Yiǧit, Vahit
AU - Yirdaw, Birhanu Wubale
AU - Yonemoto, Naohiro
AU - Yu, Chuanhua
AU - Yunusa, Ismaeel
AU - Zamani, Mohammad
AU - Zastrozhin, Mikhail Sergeevich
AU - Zastrozhina, Anasthasia
AU - Zhang, Zhi Jiang
AU - Zhao, Jeff T.
AU - Murray, Christopher J.L.
AU - Davis, Adrian C.
AU - Vos, Theo
AU - Chadha, Shelly
N1 - Funding Information: LMH reports personal fees from WHO, outside the submitted work. PSB reports personal fees from WHO, outside the submitted work. CRC reports support from the UK National Institute for Health Research (NIHR) Biomedical Research Centre. B-FH was partially supported by China Medical University (CMU109-MF-63), Taichung, Taiwan. SMSI reports grants from National Heart Foundation of Australia and National Health and Medical Research Council (NHMRC); personal fees from WHO; and partial funding by the National Heart Foundation of Australia and NHMRC, outside the submitted work. WM is program analyst in population and development at the UN Population Fund country office in Peru, which does not necessarily endorse this study. JAS reports consultancy fees from Crealta/Horizon, Medisys, Fidia, Two labs, Adept Field Solutions, Clinical Care options, Clearview Healthcare Partners, Putnam Associates, Focus Forward, Navigant Consulting, Spherix, MedIQ, UBM, Trio Health, Medscape, WebMD, Practice Point communications, the National Institutes of Health, and the American College of Rheumatology; payment for lectures including service on Simply Speaking speaker's bureau; stock ownership in TPT Global Tech, Vaxart pharmaceuticals, and Charlotte's Web Holdings. JAS previously owned stock options in Amarin, Viking, and Moderna pharmaceuticals; held placement on the steering committee of OMERACT, an international organisation that develops measures for clinical trials and receives arm's length funding from 12 pharmaceutical companies; serves on the US Food and Drug Administration Arthritis Advisory Committee; is a member of the Veterans Affairs Rheumatology Field Advisory Committee; and is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. ACD reports sponsorship for meeting from GN Foundation; personal fees from GN UK and EarGym; and grants from Siemens/Sivantos UK, during the conduct of the study. ACD has a patent, HearCheck Screener (University of Manchester), with royalties paid through the University of Manchester, and is a member of the WHO Technical Group for World Hearing Repor. All other authors declare no competing interests. Funding Information: The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of institutions with which they are affiliated. This manuscript was produced as part of the GBD Collaborator Network and in accordance with the GBD protocol. TWB acknowledges support by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. AAB acknowledges funding (FRGS/1/2017/SKK06iUNISZA/02/1) under Kementerian Pendidikan Malaysia and Universiti Sultan Zainal Abidin focusing on Streptococcus pneumoniae as one of the main causes of otitis media globally. IL is member of the Sistema Nacional de Investigaci?n, which is supported by the Secretar?a Nacional de Ciencia, Tecnolog?a e Innovaci?n, Panama. JRP acknowledges the support towards research given by Manipal Academy of Higher Education, Manipal, India. AMS acknowledges support from the Egyptian Fulbright Mission Program. MMS-M acknowledges the support of the Ministry of Education, and Science and Technological Development of the Republic of Serbia (Contract 175087). The views expressed herein do not represent those of the NIHR or the UK Department of Health and Social Care. Funding Information: The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of institutions with which they are affiliated. This manuscript was produced as part of the GBD Collaborator Network and in accordance with the GBD protocol. TWB acknowledges support by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. AAB acknowledges funding (FRGS/1/2017/SKK06iUNISZA/02/1) under Kementerian Pendidikan Malaysia and Universiti Sultan Zainal Abidin focusing on Streptococcus pneumoniae as one of the main causes of otitis media globally. IL is member of the Sistema Nacional de Investigación, which is supported by the Secretaría Nacional de Ciencia, Tecnología e Innovación, Panama. JRP acknowledges the support towards research given by Manipal Academy of Higher Education, Manipal, India. AMS acknowledges support from the Egyptian Fulbright Mission Program. MMS-M acknowledges the support of the Ministry of Education, and Science and Technological Development of the Republic of Serbia (Contract 175087). The views expressed herein do not represent those of the NIHR or the UK Department of Health and Social Care. Publisher Copyright: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2021/3/13
Y1 - 2021/3/13
N2 - Background: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. Methods: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested meta-regression models for severity-specific prevalence, accounting for hearing aid coverage, cause, and the presence of tinnitus. We also forecasted the prevalence of hearing loss until 2050. Findings: An estimated 1·57 billion (95% uncertainty interval 1·51–1·64) people globally had hearing loss in 2019, accounting for one in five people (20·3% [19·5–21·1]). Of these, 403·3 million (357·3–449·5) people had hearing loss that was moderate or higher in severity after adjusting for hearing aid use, and 430·4 million (381·7–479·6) without adjustment. The largest number of people with moderate-to-complete hearing loss resided in the Western Pacific region (127·1 million people [112·3–142·6]). Of all people with a hearing impairment, 62·1% (60·2–63·9) were older than 50 years. The Healthcare Access and Quality (HAQ) Index explained 65·8% of the variation in national age-standardised rates of years lived with disability, because countries with a low HAQ Index had higher rates of years lived with disability. By 2050, a projected 2·45 billion (2·35–2·56) people will have hearing loss, a 56·1% (47·3–65·2) increase from 2019, despite stable age-standardised prevalence. Interpretation: As populations age, the number of people with hearing loss will increase. Interventions such as childhood screening, hearing aids, effective management of otitis media and meningitis, and cochlear implants have the potential to ameliorate this burden. Because the burden of moderate-to-complete hearing loss is concentrated in countries with low health-care quality and access, stronger health-care provision mechanisms are needed to reduce the burden of unaddressed hearing loss in these settings. Funding: Bill & Melinda Gates Foundation and WHO.
AB - Background: Hearing loss affects access to spoken language, which can affect cognition and development, and can negatively affect social wellbeing. We present updated estimates from the Global Burden of Disease (GBD) study on the prevalence of hearing loss in 2019, as well as the condition's associated disability. Methods: We did systematic reviews of population-representative surveys on hearing loss prevalence from 1990 to 2019. We fitted nested meta-regression models for severity-specific prevalence, accounting for hearing aid coverage, cause, and the presence of tinnitus. We also forecasted the prevalence of hearing loss until 2050. Findings: An estimated 1·57 billion (95% uncertainty interval 1·51–1·64) people globally had hearing loss in 2019, accounting for one in five people (20·3% [19·5–21·1]). Of these, 403·3 million (357·3–449·5) people had hearing loss that was moderate or higher in severity after adjusting for hearing aid use, and 430·4 million (381·7–479·6) without adjustment. The largest number of people with moderate-to-complete hearing loss resided in the Western Pacific region (127·1 million people [112·3–142·6]). Of all people with a hearing impairment, 62·1% (60·2–63·9) were older than 50 years. The Healthcare Access and Quality (HAQ) Index explained 65·8% of the variation in national age-standardised rates of years lived with disability, because countries with a low HAQ Index had higher rates of years lived with disability. By 2050, a projected 2·45 billion (2·35–2·56) people will have hearing loss, a 56·1% (47·3–65·2) increase from 2019, despite stable age-standardised prevalence. Interpretation: As populations age, the number of people with hearing loss will increase. Interventions such as childhood screening, hearing aids, effective management of otitis media and meningitis, and cochlear implants have the potential to ameliorate this burden. Because the burden of moderate-to-complete hearing loss is concentrated in countries with low health-care quality and access, stronger health-care provision mechanisms are needed to reduce the burden of unaddressed hearing loss in these settings. Funding: Bill & Melinda Gates Foundation and WHO.
UR - http://www.scopus.com/inward/record.url?scp=85102311300&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(21)00516-X
DO - 10.1016/S0140-6736(21)00516-X
M3 - Article
C2 - 33714390
SN - 0140-6736
VL - 397
SP - 996
EP - 1009
JO - The Lancet
JF - The Lancet
IS - 10278
ER -